How long does lithium withdrawal last
Pro Research Analysisby 
Searched over 200M research papers
Duration and Effects of Lithium Withdrawal
Introduction to Lithium Withdrawal
Lithium is a common treatment for bipolar disorder and other mood disorders. However, discontinuing lithium can lead to withdrawal symptoms and a potential relapse of manic or depressive episodes. Understanding the duration and effects of lithium withdrawal is crucial for managing patient care effectively.
Duration of Lithium Withdrawal Symptoms
Initial Withdrawal Phase: First Few Days
Research indicates that some withdrawal symptoms can appear almost immediately after discontinuation. For instance, a study found that within 24 hours of stopping lithium, there was a noticeable increase in mania symptoms in patients4. Another study reported that three patients relapsed within just four days of abrupt lithium discontinuation2.
Short-Term Withdrawal: First Three Months
The first three months following lithium withdrawal are critical. During this period, significantly more patients experience relapses compared to those who continue their medication1. This suggests that the initial three months are a high-risk period for withdrawal symptoms and relapse.
Long-Term Effects: Beyond Three Months
After the initial three months, the relapse rate for those who discontinued lithium aligns with those who never took the drug1. This indicates that while the immediate withdrawal period is fraught with risks, the long-term prognosis may not be significantly different from those who were never on lithium.
Clinical Implications of Lithium Withdrawal
Risk of Manic Recurrence
The risk of manic recurrence soon after lithium withdrawal is well-documented. Studies have shown that a significant number of patients relapse into mania within a few weeks of stopping lithium3 5. This rapid recurrence underscores the importance of careful management when discontinuing lithium.
Physical Withdrawal Symptoms
Physical symptoms such as tremors, polyuria, muscular weakness, polydipsia, and dry mouth tend to reduce significantly after lithium withdrawal2. These symptoms are generally short-lived and diminish within the first few days to weeks after stopping the medication.
Long-Term Health Implications
Long-term lithium use can affect renal function, but some improvements in glomerular filtration rate (GFR) have been observed after discontinuation9. However, maximal urinary concentrating capacity may not improve, indicating some irreversible effects on renal function9.
Conclusion
Lithium withdrawal can lead to immediate and short-term symptoms, with a high risk of relapse within the first three months. Physical withdrawal symptoms tend to diminish quickly, but the risk of manic recurrence remains significant. Long-term health implications, particularly concerning renal function, should be monitored closely. Proper management and gradual tapering of lithium are essential to mitigate these risks and ensure patient safety.
Sources and full results
Most relevant research papers on this topic
Is There a Lithium Withdrawal Syndrome?
Lithium withdrawal exists as a clinical phenomenon, and long-term treatment with lithium does not improve long-term prognosis.
Abrupt lithium discontinuation in manic‐depressive patients
Abrupt lithium discontinuation in manic-depressive patients significantly reduced symptoms, but three patients relapsed within 4 days, suggesting a rebound phenomenon.
RCTRecurrence of Mania after Lithium Withdrawal
The risk of a manic recurrence shortly after lithium withdrawal in bipolar patients has major implications for how we should employ lithium treatment.
Highly CitedA behavioral-biochemical study of lithium treatment.
Lithium withdrawal leads to a definite increase in mania within 24 hours, offering advantages in clinical use and research.
RCTHighly CitedRAPID RECURRENCE OF MANIA FOLLOWING ABRUPT DISCONTINUATION OF LITHIUM
Rapid relapse of mania can occur 13-19 days after abrupt discontinuation of lithium in patients with a history of mania.
RCTHighly CitedProphylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.
Lithium is significantly preferred over placebo in treating manic-depressive and recurrent-depressive disorders, with no relapses observed during the five-month trial.
RCTHighly CitedCombined lithium and valproate treatment and subsequent withdrawal: Serotonergic mechanism of their interaction in discrete brain regions
Combined administration of lithium and valproate leads to persistent decrease in 5-hydroxytryptamine synthesis and turnover in the brain, even after 2 days of treatment withdrawal.
Non-RCT
Animal StudyLithium treatment during alcoholic withdrawal
Oral lithium carbonate reduces subjective symptoms and normalizes motor tracking performance in mild alcoholic withdrawal, but does not significantly alter blood pressure, heart rate, or sleep patterns.
Non-RCTRenal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study.
Long-term lithium use can lead to irreversible reductions in urinary concentrating capacity, while GFR remains well preserved in most patients.
Highly CitedRecurrence of affective illness after withdrawal of long‐term lithium treatment
Long-term lithium treatment in manic-depressive patients leads to relapses of affective episodes, but these relapses tend to be spread over months, with no immediate and inevitable'rebound' of psychotic episodes.
Observational Study